Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BIOVERATIV THERAPEUTICS INC.”

57 pharma patents match "BIOVERATIV THERAPEUTICS INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 57
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 57 pharmaceutical patents matching "BIOVERATIV THERAPEUTICS INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

57 results for “BIOVERATIV THERAPEUTICS INC.” · 30,257 patents in full index Clear search

  1. US 9867873

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted
  2. US 9856468

    Processable single chain molecules and polypeptides made using same

    BIOVERATIV THERAPEUTICS INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  3. US 9725496

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  4. US 9675676

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  5. US 9670475

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  6. US 9636416

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  7. US 9629903

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  8. US 9623088

    Factor VIII polypeptide formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  9. US 9623091

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted